Acute toxicity of the bowel after stereotactic robotic radiotherapy for abdominopelvic oligometastases
Author:
Affiliation:
1. Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;
2. Department of Gastroenterology, Erasmus MC, Rotterdam, The Netherlands;
3. Department of Surgical Oncology, Erasmus MC, Rotterdam, The Netherlands
Publisher
Informa UK Limited
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1378432
Reference27 articles.
1. Quality of Life After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors
2. Survival and Treatment of Non-small Cell Lung Cancer Stage I–II Treated Surgically or with Stereotactic Body Radiotherapy: Patient and Tumor-Specific Factors Affect the Prognosis
3. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
4. Four-dimensional Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer: A Comparative Planning Study
5. The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Dose Distribution Due to Change in Bowel Position in Patients Treated with SBRT for a Target Lesion Neighboring the Intestine;International Journal of Hematology and Oncology;2022-09-30
2. Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review;Translational Lung Cancer Research;2021-07
3. Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy;Frontiers in Oncology;2021-01-18
4. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document;Radiotherapy and Oncology;2020-07
5. Toxicity Management for Upper Abdomen Tumors in Radiation Oncology;Prevention and Management of Acute and Late Toxicities in Radiation Oncology;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3